Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Cystic Fibrosis Drug Developer N30 Pharmaceuticals Raises $30M 11/20/14 Boulder/Denver
CF Foundation Cashes Out on Kalydeco in $3.3B Sale to Royalty Pharma 11/19/14 Boston
Servier Inks $1B Deal for Intarcia’s Implantable Diabetes Device 11/12/14 Boston
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
BioPontis, Reborn as Nonprofit, Takes On Rare Disease Drugs 10/20/14 Raleigh Durham
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
Alios’s Corporate Venture Backers Ride RSV (And Hep C) To Big Payday 10/01/14 San Francisco
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Vertex Stock Up 40 Percent After Cystic Fibrosis Trial Results 06/24/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund 04/01/14 San Francisco
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
Vertex Looks to Patient Subset as CF Drug Misses Mark in Latest Study 12/19/13 Boston
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Vertex Sells Hep C Drug Royalty Rights to Janssen for $152M 11/20/13 Boston
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Vertex Cuts 15% of Workforce as Hepatitis C Drug Sales Drop 10/29/13 Boston
The Best Biotech Graduate Schools in Real Life 09/23/13 National
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
New Data Could Open Vertex’s CF Drug to 400 More Patients 07/29/13 Boston
East Coast Life Sciences Roundup: Sarepta, Agios, Gerngross, & (Much) More 07/26/13 Boston
Page 1 of 10 next page »